Julia Oblander
Overview
Explore the profile of Julia Oblander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jann J, Streuer A, Hecht A, Nolte F, Nowak V, Danner J, et al.
Leuk Lymphoma
. 2020 Jul;
61(13):3066-3077.
PMID: 32723198
Although acute promyelocytic leukemia (APL) has evolved to the AML entity with the best prognosis, typical 'early death' (ED) events still account for mortality rates of ∼20% in population-based studies....
12.
Jann J, Nolte F, Mossner M, Flach J, Altrock E, Schmitt N, et al.
Leuk Res
. 2019 May;
82:15-18.
PMID: 31132434
No abstract available.
13.
Genomic CDKN2A/2B deletions in adult Ph ALL are adverse despite allogeneic stem cell transplantation
Pfeifer H, Raum K, Markovic S, Nowak V, Fey S, Oblander J, et al.
Blood
. 2018 Jan;
131(13):1464-1475.
PMID: 29348129
We investigated the role of copy number alterations to refine risk stratification in adult Philadelphia chromosome positive (Ph) acute lymphoblastic leukemia (ALL) treated with tyrosine kinase inhibitors (TKIs) and allogeneic...
14.
Jann J, Nowak D, Nolte F, Fey S, Nowak V, Oblander J, et al.
J Med Genet
. 2017 Jun;
54(9):640-650.
PMID: 28600436
Background: Cytogenetic aberrations such as deletion of chromosome 5q (del(5q)) represent key elements in routine clinical diagnostics of haematological malignancies. Currently established methods such as metaphase cytogenetics, FISH or array-based...
15.
Mossner M, Jann J, Wittig J, Nolte F, Fey S, Nowak V, et al.
Blood
. 2016 Jun;
128(9):1246-59.
PMID: 27268087
Clonal evolution is believed to be a main driver for progression of various types of cancer and implicated in facilitating resistance to drugs. However, the hierarchical organization of malignant clones...
16.
Medyouf H, Mossner M, Jann J, Nolte F, Raffel S, Herrmann C, et al.
Cell Stem Cell
. 2014 Apr;
14(6):824-37.
PMID: 24704494
Myelodysplastic syndromes (MDSs) are a heterogeneous group of myeloid neoplasms with defects in hematopoietic stem and progenitor cells (HSPCs) and possibly the HSPC niche. Here, we show that patient-derived mesenchymal...
17.
Mossner M, Nolte F, Hutter G, Reins J, Klaumunzer M, Nowak V, et al.
J Med Genet
. 2013 Jan;
50(2):108-17.
PMID: 23339109
Background: Investigation of X-chromosome inactivation patterns (XCIP) by determination of differential CpG-methylation has been widely applied for investigation of female cell clonality. Using this approach the clonal origin of various...